Solid Tumor

Treatment stage
Short Name
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Advanced Solid Tumors MYTHIC

Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors

NCT4855656 Andrea Standish, RN  Eligibility Criteria 
Advanced Solid Tumors MAGNETIC Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination with Gemcitabine for the Treatment of Advanced Solid Tumors  NCT05147272 Andrea Standish, RN  Eligibility Criteria
Advanced Solid Tumors FAETH A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss NCT05300048 Katie Elkins

Eligibility Criteria

Enrollment on Hold

Advanced Solid Tumors ATRIN A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors NCT04905914 Andrea Standish, RN Eligibility Criteria